I will say one thing. CFIUS is not covering our research contracts with universities that can provide parties of concern access to technology that's being developed. That was a decision in the United States not to subject that to CFIUS, but some other countries, like Denmark and I believe the U.K., are considering that. There are some jurisdictions that are more expansive.
While I have the floor, I'll go back to one of the other questions. One of the questions I was asked was what might happen if the bill doesn't pass. I will note that, in my experience, Canada mitigates transactions less frequently than some other countries, particularly within the G7, and perhaps it could be because it's more difficult. In the U.S., for example, CFIUS uses litigation quite frequently to allow the economic benefit while adding terms to the transaction.
I'll also note with respect to that other question that I think it's an important feature of the bill.